The 13th Academic Conference on Radiation Oncology in Western China was held in Chengdu from August 2 to 5, 2018. The conference was hosted by the Western Association for Radiation Therapy and the Sichuan Provincial Western Association for Radiation Therapy, organized by the Sichuan Provincial Western Association for Radiation Therapy and Sichuan Cancer Hospital, and co-organized by the Sichuan Anti-Cancer Association.
The Academic Conference on Radiation Oncology in Western China serves as an academic platform leading the development direction of radiation oncology in western China. Professor Lang Jinyi, Chairman of the 8th Committee of the Chinese Society of Clinical Oncology (CSCO) for Radiation Oncology and President of the Cancer Hospital Affiliated to the School of Medicine, University of Electronic Science and Technology of China (Sichuan Cancer Hospital), attended the opening ceremony and delivered a welcome address. Numerous standing committee members and experts from the Chinese Society of Clinical Oncology (CSCO) for Radiation Oncology attended the conference, exchanging insights on recent clinical achievements in radiation oncology in western China and the latest progress in multicenter collaborative research projects.
As a global leader and technology provider in top-tier medical artificial intelligence, Baishi Medical showcased its automated delineation system for clinical target volumes in nasopharyngeal carcinoma radiotherapy during the conference.

Baishi Medical at the Exhibition Booth of the 13th Western Region Academic Conference on Radiation Oncology
Baishi Medical’s automated contouring system for clinical target volumes in nasopharyngeal carcinoma radiotherapy can simultaneously delineate the GTV (Gross Tumor Volume) and CTV (Clinical Target Volume). The product has been integrated into Philips’ IntelliSpace Discovery (ISD) platform, and related research findings were accepted as oral presentations at the Radiological Society of North America (RSNA) annual meetings for two consecutive years (RSNA 2017 and RSNA 2018). This solution significantly enhances the workflow efficiency of radiation oncologists, reducing the time required for target volume contouring per nasopharyngeal carcinoma patient from 2–4 hours to under one minute, with contouring accuracy comparable to that of nasopharyngeal carcinoma radiotherapy experts.
In addition to possessing a globally leading system for delineating radiotherapy surgical target volumes in nasopharyngeal carcinoma, Baishi Medical offers comprehensive analysis and detection solutions for all pulmonary diseases, as well as domestically leading systems for breast cancer detection and diagnosis, liver cancer auxiliary diagnosis, and AI-assisted pathological analysis. This has established a multi-modal, multi-disease product portfolio that truly delivers high-value, implementable solutions for departments of radiology, pathology, and radiation oncology.

Follow the BAI SHI Medical official account for more information.